Codes / ICD10CM / C85.03

C85.03 Lymphosarcoma, intra-abdominal lymph nodes

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Lymphosarcoma, intra-abdominal lymph nodes
  • C85.03

Summary

Lymphosarcoma, intra-abdominal lymph nodes, is a type of non-Hodgkin lymphoma (NHL) that specifically involves the lymph nodes within the abdominal cavity. This condition affects the lymphatic system, part of the immune system, and involves abnormal growth of lymphoid cells. The term "lymphosarcoma" is a historical classification now categorized under NHL.

Causes

The exact cause of lymphosarcoma in intra-abdominal lymph nodes is often unknown but involves genetic mutations in lymphocytes. Factors such as viral infections, immune system disorders, or exposure to certain chemicals may contribute to its development. These mutations disrupt normal cell regulation, leading to uncontrolled growth.

Risk Factors

  • Advanced age (more common in older adults)
  • Weakened immune system (e.g., HIV/AIDS, immunosuppressive therapy)
  • Certain infections (e.g., Epstein-Barr virus, H. pylori)
  • Exposure to chemicals (e.g., pesticides, herbicides)
  • Family history of lymphoma
  • Autoimmune conditions (e.g., rheumatoid arthritis)

Symptoms

  • Abdominal pain or swelling
  • Unexplained weight loss
  • Fever or night sweats
  • Fatigue or weakness
  • Nausea or vomiting
  • Changes in bowel habits

Diagnosis

Diagnosis typically involves a combination of imaging studies (e.g., CT or MRI scans) to identify abnormal lymph nodes in the abdomen, followed by a biopsy to confirm the presence of lymphoma. Blood tests may also be performed to assess overall health and detect markers associated with lymphoma. Additional tests, such as bone marrow biopsy or PET scans, may be used to stage the disease and determine the extent of spread.

Treatment Options

Treatment depends on the stage and aggressiveness of the lymphoma and may include chemotherapy, immunotherapy, radiation therapy, or a combination of these. Targeted therapies or stem cell transplantation may be considered for certain cases. Treatment plans are tailored to the individual patient and may involve a multidisciplinary team of specialists.

Prognosis and Follow-Up

Prognosis varies based on factors such as the lymphoma subtype, stage at diagnosis, and patient response to treatment. Regular follow-up appointments are essential to monitor for recurrence or progression. Long-term surveillance may include periodic imaging and blood tests to detect any changes early.

Complications

Potential complications include bowel obstruction, organ damage due to tumor growth, infection from a weakened immune system, or side effects from treatment (e.g., nausea, fatigue, or increased infection risk). In advanced cases, the lymphoma may spread to other parts of the body.

Lifestyle & Prevention

While lymphosarcoma cannot always be prevented, maintaining a healthy immune system through balanced nutrition, regular exercise, and avoiding known risk factors (e.g., excessive chemical exposure) may support overall health. Patients should avoid smoking and limit alcohol consumption, as these can weaken the immune system.

When to Seek Professional Help

Seek medical attention if you experience persistent abdominal pain, unexplained weight loss, fever, or other symptoms that do not improve. Early evaluation is important for timely diagnosis and treatment. Contact a healthcare provider if symptoms worsen or new symptoms develop.

Tips for Medical Coders

When coding for C85.03, ensure the documentation specifies "intra-abdominal lymph nodes" to confirm the correct site. Verify that the diagnosis aligns with the clinical findings and that no more specific lymphoma codes apply. Document the location and extent of lymph node involvement to support accurate coding.

Book a walkthrough

C85.03 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.